| Tretinoin | Approved Investigational Nutraceutical | CAMK1 | 8536 |
upregulated | Tretinoin results in increased expression of CAMK1 mRNA | 3p25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMK1D | 57118 |
downregulated | Tretinoin results in decreased expression of CAMK1D mRNA | 10p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMK2B | 816 |
downregulated | Tretinoin results in decreased expression of CAMK2B mRNA | 7p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMK2D | 817 |
upregulated | Tretinoin results in increased expression of CAMK2D mRNA | 4q26 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMK2G | 818 |
upregulated | Tretinoin results in increased expression of CAMK2G mRNA | 10q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMK2N1 | 55450 |
upregulated | Tretinoin results in increased expression of CAMK2N1 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMKMT | 79823 |
downregulated | Tretinoin results in decreased expression of CAMKMT mRNA | 2p21 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMKV | 79012 |
downregulated | Tretinoin results in decreased expression of CAMKV mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMSAP2 | 23271 |
upregulated | Tretinoin results in increased expression of CAMSAP2 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMTA1 | 23261 |
downregulated | Tretinoin results in decreased expression of CAMTA1 mRNA | 1p36.31-p36.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CAMTA2 | 23125 |
upregulated | Tretinoin results in increased expression of CAMTA2 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CAPG | 822 |
upregulated | Tretinoin results in increased expression of CAPG mRNA | 2p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CAPN10 | 11132 |
upregulated | Tretinoin results in increased expression of CAPN10 mRNA | 2q37.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CAPN6 | 827 |
downregulated | Tretinoin results in decreased expression of CAPN6 mRNA | Xq23 | |
| Tretinoin | Approved Investigational Nutraceutical | CAPRIN1 | 4076 |
downregulated | Tretinoin results in decreased expression of CAPRIN1 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CAPS | 828 |
downregulated | Tretinoin results in decreased expression of CAPS mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CARD10 | 29775 |
upregulated | Tretinoin results in increased expression of CARD10 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CARD6 | 84674 |
upregulated | Tretinoin results in increased expression of CARD6 mRNA | 5p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CARD9 | 64170 |
downregulated | Tretinoin results in decreased expression of CARD9 mRNA | 9q34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CASP1 | 834 |
upregulated | Tretinoin results in increased expression of CASP1 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CASP6 | 839 |
downregulated | Tretinoin results in decreased expression of CASP6 mRNA | 4q25 | |
| Tretinoin | Approved Investigational Nutraceutical | CASP7 | 840 |
upregulated | Tretinoin results in increased expression of CASP7 mRNA | 10q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CASP9 | 842 |
upregulated | Tretinoin results in increased expression of CASP9 mRNA | 1p36.21 | |
| Tretinoin | Approved Investigational Nutraceutical | CASZ1 | 54897 |
downregulated | Tretinoin results in decreased expression of CASZ1 mRNA | 1p36.22 | |
| Tretinoin | Approved Investigational Nutraceutical | CAV1 | 857 |
downregulated | Tretinoin results in decreased expression of CAV1 mRNA | 7q31.2 | |